BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17212318)

  • 1. [Evidence for low-dosage prednisolone in early rheumatoid arthritis. Prevents destruction of the joints and relieves symptoms].
    Svensson B; Hafström I
    Lakartidningen; 2006 Nov 22-28; 103(47):3704-9. PubMed ID: 17212318
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reconsideration of glucocorticoid therapy for rheumatoid arthritis].
    Ichikawa Y
    Ryumachi; 2002 Dec; 42(6):859-62. PubMed ID: 12632604
    [No Abstract]   [Full Text] [Related]  

  • 4. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
    [No Abstract]   [Full Text] [Related]  

  • 5. [New therapy approaches in rheumatoid arthritis. Preventing early joint destruction].
    Adam O; Forth W
    MMW Fortschr Med; 2001 Feb; 143(8):27-30. PubMed ID: 11265533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
    J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and management of early rheumatoid arthritis].
    Yamamoto S
    Ryumachi; 1998 Oct; 38(5):752-61. PubMed ID: 9852754
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug management of early rheumatoid arthritis - 2008.
    Sokka T; Mäkinen H
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):93-102. PubMed ID: 19233049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years.
    Santiago T; da Silva JA
    Ann N Y Acad Sci; 2014 May; 1318():41-9. PubMed ID: 24814757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracorporeal therapy of rheumatoid arthritis].
    Aseeva EA; Solov'ev SK; Chiklikchi AS
    Ter Arkh; 2001; 73(6):70-5. PubMed ID: 11521529
    [No Abstract]   [Full Text] [Related]  

  • 11. Rheumatoid arthritis: not yet curable with early intensive therapy.
    Emery P
    Lancet; 1997 Aug; 350(9074):304-5. PubMed ID: 9251629
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects on joint destruction and remission, bone turnover and lack of influence on atherogenesis: a review of the BARFOT low-dose prednisolone studies on patients with early RA.
    Svensson B; Hafström I
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S63-7. PubMed ID: 22018186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
    Tengstrand B; Larsson E; Klareskog L; Hafström I
    Scand J Rheumatol; 2007; 36(5):351-8. PubMed ID: 17963164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucocorticoids].
    Gromnica-Ihle E
    Z Rheumatol; 2016 Aug; 75(6):591-4. PubMed ID: 27412667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Randomized controlled clinical trials for IgA nephropathies].
    Yoshikawa T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():123-9. PubMed ID: 17899839
    [No Abstract]   [Full Text] [Related]  

  • 16. Prednisolone in early rheumatoid arthritis: an antiinvasive effect.
    Harris ED
    Arthritis Rheum; 2005 Nov; 52(11):3324-5. PubMed ID: 16255013
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.
    Metselaar JM; Wauben MH; Boerman OC; Van Lent PL; Storm G
    Cell Mol Biol Lett; 2002; 7(2):291-2. PubMed ID: 12097962
    [No Abstract]   [Full Text] [Related]  

  • 18. Are glucocorticoids DMARDs?
    Bijlsma JW; Hoes JN; Van Everdingen AA; Verstappen SM; Jacobs JW
    Ann N Y Acad Sci; 2006 Jun; 1069():268-74. PubMed ID: 16855154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early prediction of joint destruction in rheumatoid arthritis].
    Eguchi K
    Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.